As more and more EMT pathways are being discovered, we believe that inhibition of the TGF-β signaling pathway can inhibit EMT and reduce myofibroblast activation, which may effectively assist the treatment of IPF. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.